SOURCE: OmniComm Systems, Inc.

March 04, 2008 09:10 ET

OmniComm Systems, Inc. to Steer Industry Panel of Clinical Trial Professionals at Upcoming 23rd Annual DIA Conference and Exhibition, March 16-18, 2008

Company Executives Will Drive Sessions and Deliver Presentations on Implementation and Change Process for Effectively Using Electronic Data Capture (EDC) in Clinical Trials

FT. LAUDERDALE, FL--(Marketwire - March 4, 2008) - OmniComm Systems, Inc. (OTCBB: OMCM), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that several of the company's industry veterans will be participating in thought provoking sessions at the upcoming DIA meeting. Presenters will showcase a variety of business examples that will explore the essential process transformation needed for putting EDC into practice for clinical trials. The sessions will consider the fundamental changes that are critical for using EDC successfully.

Drug Information Association
23rd Annual DIA Conference and Exhibition
Data Management in Transition: Putting the "e" in Data Management
March 16-18, 2008
JW Marriott Hotel
Washington, DC

Monday, 3-17-2008
Track 2 CDM: 3-5 PM
Project Management Best Practices: Making Them Work for You
EDC Conversion for Data Management
Colleen Lockwood, Project Manager, OmniComm Systems, Inc.

Tuesday, 3-18-2008
Track 1 CDM: 8:30-10 AM
Business Transformation to Realize the Value of EDC:
 Session Chair, Ken Light, Senior Vice President Professional Services,
 OmniComm Systems, Inc.
EDC Applications: Managing the Evolution
 Jill Dinsdale, Senior Clinical Data Associate, Gilead Sciences
Leading EDC Practices and Process Improvements to Ensure Business Benefit
 Ken Light, Sr. VP Professional Services, OmniComm Systems, Inc.
Balancing the Benefits of EDC: Speed, Cost and Quality
 Sondra Smyrnios, (formerly CEO, Evia Clinical Services LLC),
 Senior Vice President, Clinical Operations, OmniComm Systems, Inc.

About OmniComm

OmniComm Systems, Inc. ( provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. OmniComm's growing base of satisfied customers is a direct result of the company's commitment to deliver products and services that ensure ease of use, faster study build, ease of integration and better performance. OmniComm's client intuitive pricing model allows companies that range from small to mid-size to large scale institutions to safely and efficiently capitalize on their clinical research investments.

OmniComm ranked in the top 150 as one of the fastest revenue growth technology companies in North America during the last 5 years. OmniComm Systems, Inc. has corporate headquarters in Ft. Lauderdale, Florida with offices in Bonn, Germany, Tula, Russia, California, Maryland, New York, North Carolina and Texas.

Safe Harbor Disclaimer

Statements about OmniComm's future expectations, including without limitation, future revenues and earnings, plans and objectives for the future operations, future agreements, future economic performance, operations and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. OmniComm intends that such forward-looking statements be subject to the Safe Harbors created thereby. Since these statements involve risks and uncertainties, including but not limited to economic competitive, governmental, contractual and technological factors affecting OmniComm's operations, markets and profitability, actual results could differ materially and adversely from the expected results.

Contact Information

    Lizanne Kelley
    OmniComm Systems, Inc.
    954-473-1254 Extension 283
    Email Contact